| Financial Year |
March 31 2023 |
| Monetary Funds |
2,336,967,106.06 |
| Held-for-trading Financial Assets |
3,318,431.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
27,844,994.63 |
| Advances to Suppliers |
105,288,654.98 |
| Other Receivables |
1,326,335,477.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
12,050,088,132.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
780,192,573.09 |
| Total Current Assets |
16,630,035,369.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
301,211,996.03 |
| Investment Properties |
3,757,196,777.53 |
| Fixed Assetes |
633,192,919.22 |
| Under-construction Projects |
101,401,515.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
80,864,591.58 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
182,291,862.28 |
| Deferred Income Tax Assets |
402,841,084.01 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
6,164,059,405.56 |
| Total Assets |
22,794,094,775.01 |
| Short-Term Loans |
196,805,767.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
115,087,405.04 |
| Accounts Payable |
3,562,442,696.14 |
| Accounts Received In Advance |
5,686,686.58 |
| Employee Compensation Payable |
56,319,042.41 |
| Taxes Payable |
532,500,397.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,557,286,082.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,532,113,135.56 |
| Other Current Liabilities |
2,260,776,189.38 |
| Sub-Total of Current Liabilities |
12,256,649,157.78 |
| Long-term Loans |
2,855,740,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,331,872.90 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,706,455,626.93 |
| Total Liabilities |
15,963,104,784.71 |
| Paid-In Capital(Or Share Stock) |
3,268,438,122.00 |
| Capital Surplus |
1,538,905,680.70 |
| Surplus Reserve |
242,798,814.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,695,901,639.04 |
| Minority Stockholder's Interest |
100,594,853.79 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,730,395,136.51 |
| Owner's Equity（Stockholder's Equity） |
6,830,989,990.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,794,094,775.01 |
